An inhaler for electronically supervised parenteral administration of a dry powder pharmaceutical composition comprising: storage means for the pharmaceutical composition in a form of a dry powder; administration means for administration of the pharmaceutical composition, provided with a mixing chamber and airflow channels; memory and processing means; communication means; controlled blocking means for blocking administration of the pharmaceutical composition, wherein the inhaler is adapted to be registered with an authorisation token assigned to a mobile device, to receive data corresponding to an administration scheme, the inhaler is further adapted to determine whether in the proximity of the inhaler there is present the mobile device with the registered authorisation token assigned thereto by an authorised entity (100, 200) entitled to qualify for therapy with a use of the pharmaceutical composition with at least one terminal that is generating a control signal with an administration scheme and the authorisation token, and in response to registration of the authorisation token assigned to the mobile device in the inhaler, the inhaler is configured to process the administration scheme, by making the administration scheme an active administration scheme and allowing administration of the doses of a pharmaceutical composition in a time window indicated by the administration scheme, such that the inhaler controls the controlled blocking means so as to allow administration of the pharmaceutical composition only with compliance with the administration scheme, and in the presence of the mobile device with the registered authorisation token assigned thereto by the authorised entity (100, 200). storage means for the pharmaceutical composition in a form of a dry powder; administration means for administration of the pharmaceutical composition, provided with a mixing chamber and airflow channels; memory and processing means; communication means; controlled blocking means for blocking administration of the pharmaceutical composition, wherein the inhaler is adapted to be registered with an authorisation token assigned to a mobile device, to receive data corresponding to an administration scheme, the inhaler is further adapted to determine whether in the proximity of the inhaler there is present the mobile device with the registered authorisation token assigned thereto by an authorised entity (100, 200) entitled to qualify for therapy with a use of the pharmaceutical composition with at least one terminal that is generating a control signal with an administration scheme and the authorisation token, and in response to registration of the authorisation token assigned to the mobile device in the inhaler, the inhaler is configured to process the administration scheme, by making the administration scheme an active administration scheme and allowing administration of the doses of a pharmaceutical composition in a time window indicated by the administration scheme, such that the inhaler controls the controlled blocking means so as to allow administration of the pharmaceutical composition only with compliance with the administration scheme, and in the presence of the mobile device with the registered authorisation token assigned thereto by the authorised entity (100, 200). to be registered with an authorisation token assigned to a mobile device, to receive data corresponding to an administration scheme, the inhaler is further adapted to determine whether in the proximity of the inhaler there is present the mobile device with the registered authorisation token assigned thereto by an authorised entity (100, 200) entitled to qualify for therapy with a use of the pharmaceutical composition with at least one terminal that is generating a control signal with an administration scheme and the authorisation token, and in response to registration of the authorisation token assigned to the mobile device in the inhaler, the inhaler is configured to process the administration scheme, by making the administration scheme an active administration scheme and allowing administration of the doses of a pharmaceutical composition in a time window indicated by the administration scheme, such that the inhaler controls the controlled blocking means so as to allow administration of the pharmaceutical composition only with compliance with the administration scheme, and in the presence of the mobile device with the registered authorisation token assigned thereto by the authorised entity (100, 200).